
Vitor Moutinho, MD, MSc
@vitor__moutinho
Doctor • Oncologist/Surgeon • Master’s in Epidemiology • Humor connects us 🥸
ID: 181324826
21-08-2010 22:28:53
2,2K Tweet
5,5K Followers
6,6K Following

#AudioVisualAbstract : Laparoscopic #Liver Tunnel for Tumors at the #HepatocavalConfluence Nadia Russolillo Rebecca Panconesi rdcu.be/dMChK Vitor Moutinho, MD, MSc Syed A. Ahmad


July Issue: Recurrent #Intrahepatic #Cholangiocarcinoma : A 10-Point Score to Predict Post-Recurrence Survival and Guide Treatment of Recurrence Diamantis I. Tsilimigras, MD, PhD, MS Yutaka Endo 遠藤泰 Timothy M. Pawlik rdcu.be/dN7Qp Vitor Moutinho, MD, MSc Syed A. Ahmad



Delivering Impactful Scientific Oral Presentations. qxmd.com/r/38985485 by JAMA Surgery


#AudioVisualAbstract : #ConditionalOverallSurvival After Diagnosis of Non-Metastatic #ColonCancer : Impact of Laterality, MSI, and #KRAS Status Catherine Tran Paolo Goffredo, MD Jean-Nicolas Vauthey MD rdcu.be/dOVv8 Vitor Moutinho, MD, MSc Syed A. Ahmad


Philanthropist Emmet Stephenson establishes the Stephenson Prize in #PancreaticCancer Research at City of Hope with a $150 million gift that will fund pancreatic cancer researchers in the US & around the world to transform the landscape of this disease. latimes.com/business/story…


Metastases develop in 10% of esophageal cancer patients post-neoadjuvant chemoradiotherapy. Restaging may identify candidates for curative treatment, improving survival outcomes. Read more in Annals of Surgical Oncology: ow.ly/Cam650TY7li #FeaturedArticle


#AudioVisualAbstract : Effect of Hospital Cancer Designation on use of #MultimodalTherapy and Survival of Metastatic #ColorectalCancer : A State-Wide Analysis Jennie Meier Gilbert Z Murimwa, M.D. Patricio Polanco rdcu.be/d0iG8 Vitor Moutinho, MD, MSc Syed A. Ahmad

Featured: Anastomotic leak (AL) is a serious complication after ##sophagectomy . This article reports on the effect of anastomotic leak on long-term survival after esophagectomy for #EsophagealCancer . Alberto Aiolfi ow.ly/FoRs50UqepF Chris Childers Syed A. Ahmad


Featured: Development and External Validation of a Combined Clinical–Radiomic Model for Predicting Insufficient Hypertrophy of the Future Liver Remnant following Portal Vein Embolization. Ernesto Sparrelid ow.ly/3NLa50UVYmL Vitor Moutinho, MD, MSc Syed A. Ahmad


Featured: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy ( #CRSHIPEC ) to Treat #PseudomyxomaPeritonei of Ovarian Origin: A Retrospective French RENAPE Group Study naoual bakrin Witold GERTYCH ow.ly/JqrJ50UY7bs @scalpelmomma Syed A. Ahmad


February Issue: Predictors of Recurrence in Nonmetastatic #Appendiceal #EpithelialCancers : An Updated Single-Center Experience Over 25 Years rdcu.be/d9DF5 Lana Bijelic Syed A. Ahmad


The future of cancer therapy 👇🏼👇🏼 RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer @nature Vinod BalachandranMD Davendra Sohal Andrew Waters Anirban Maitra nature.com/articles/s4158…

Thought provoking work from Tarik Sammour et al. in Annals of Surgical Oncology 💯 The local regrowth trend stratified by KRAS is interesting and could certainly shape expectations. Would love to see oncologic outcomes for salvage surgery stratified by KRAS 🧐

Featured: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy ( #CRSHIPEC ) of Extraperitoneal #AbdominalDisease , is it Appropriate? ow.ly/bg7o50VxsLx Dorian Y. García-Ortega MD, MSc,PhD, FACS Syed A. Ahmad


#AudioVisualAbstract : Comparison of Prognostic Outcomes Between Repeat #LiverResection and #ParticleTherapy for Patients with Recurrent #HepatocellularCarcinoma rdcu.be/eo6KG Syed Nabeel Zafar Syed A. Ahmad